EDGAR Filing Documents for 0001193125-19-234332

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-19-234332

Filing Date

2019-08-30

Accepted

2019-08-29 20:24:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d751823ds3.htm	S-3	457939
2	EX-1.2	d751823dex12.htm	EX-1.2	210055
3	EX-4.10	d751823dex410.htm	EX-4.10	364863
4	EX-4.11	d751823dex411.htm	EX-4.11	368099
5	EX-5.1	d751823dex51.htm	EX-5.1	42346
6	EX-23.1	d751823dex231.htm	EX-23.1	1809
7	GRAPHIC	g751823g73u99.jpg	GRAPHIC	38276
8	GRAPHIC	g751823stamp73.jpg	GRAPHIC	3343
9	GRAPHIC	g751823stamp74.jpg	GRAPHIC	1837
	Complete submission text file	0001193125-19-234332.txt		1506366

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016

Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344

Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)